ARPA-H Biomedical Research Agency Gets Funding Boost In US House Appropriations Bill
Progress on appropriations follows passage of legislation in the House formally authorizing the new agency dedicated to advancing cutting edge research.
You may also be interested in...
John Crowley will take the reins at BIO in March, about a year and a half after the departure of former CEO Michelle McMurry-Heath was announced.
Pink Sheet infographic breaks down the mix of patient advocacy groups, individual patients and clinicians offering input to CMS on the first 10 drugs facing Medicare price negotiation.
US Health and Human Service Department questions recent federal court decision striking down the government’s policy of allowing plans to broadly exclude manufacturer copay assistance from counting toward patient deductibles or out-of-pocket maximums.